US EditionOcumetics Targets June 26, 2025 for Commencement of its First in Human Study
Summary by thenewswire.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study
Calgary, Alberta - TheNewswire - – June 3, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that it has set June 26, 2025 as the date for its first-in-human (FIH) clinical study. The FIH clinical study involves the implantation of the Company’s inaugural accommodating intraocular lens (the “Ocumetics Lens”) in the first gro…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
